UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [MSNBC.com]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: MSNBC.com
Pharma giantsAstraZenecaAstraZeneca's core earnings per share came in at $2.58, while analysts polled by FactSet had expected $2.53. 's core EPS was £0.47 ($0.63) versus the expected £0.43, as per FactSet.It comes as an increasing number of pharma CEOs have warned that Europe could see fewer new drugs launched amid a push by U.S. President Donald Trump to lower prices for medicines in America — unless Europe addresses some of the continent's most pressing issues impacting competitiveness.The CEOs of Novartis, AstraZeneca,Rochetold CNBCAs AstraZeneca reported earnings on Wednesday, CEO Pascal Soriot flagged a "catalyst-rich" period for the Anglo-Swedish company he has led since 2012. In April, the company said a late-stage trial for a combination treatment with cancer drug Imfinzi demonstrated meaningful improvement in the time before patients with liver cancer worsened.In late March, it surprised investors with apositive readoutAstraZeneca is on track to achieve its ambition of reachi
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis finalizes US manufacturing and R&D expansion plan with seventh new facilityGlobeNewswire
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies [CNBC]CNBC
- Novartis AG (NVS) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amidst Core Income ... [Yahoo! Finance]Yahoo! Finance
- Novartis Q1 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 4/28/26 - Miss
NVS
Sec Filings
- 4/28/26 - Form 6-K
- 3/18/26 - Form 6-K
- 3/17/26 - Form FWP
- NVS's page on the SEC website